Cite
Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy.
MLA
Wong, Jason C., et al. “Application of P21 and Klf2 Reporter Gene Assays to Identify Selective Histone Deacetylase Inhibitors for Cancer Therapy.” Bioorganic & Medicinal Chemistry Letters, vol. 21, no. 1, Jan. 2011, pp. 110–16. EBSCOhost, https://doi.org/10.1016/j.bmcl.2010.11.063.
APA
Wong, J. C., Guo, L., Peng, Z., Zhang, W., Zhang, N., Lai, W., Zhang, Z., Zhang, C., Zhang, X., Song, S., Pan, D., Xie, C., Li, J., Ning, Z., Lu, X., He, Y., & Chen, L. (2011). Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry Letters, 21(1), 110–116. https://doi.org/10.1016/j.bmcl.2010.11.063
Chicago
Wong, Jason C, Lei Guo, Zhenghong Peng, Weixing Zhang, Nan Zhang, Wayne Lai, Zhenshan Zhang, et al. 2011. “Application of P21 and Klf2 Reporter Gene Assays to Identify Selective Histone Deacetylase Inhibitors for Cancer Therapy.” Bioorganic & Medicinal Chemistry Letters 21 (1): 110–16. doi:10.1016/j.bmcl.2010.11.063.